ONGLYZA® (saxagliptin)

How do you choose the right DPP-4 inhibitor for your patients with type 2 diabetes?

Dual therapy: add-on to metformin1-3

Dual Therapy: add-on to metformin
Dual Therapy: add-on to metformin

1. De Fronzo et al. Diabetes Care 2009; 32: 1649-1655.
2. De Fronzo et al. ADA Abstr 547 Diabetes 2009; 58 (Suppl 1): A147.
3. ONGLYZA® Summary of Product Characteristics. https://www.medicines.org.uk/emc/product/6675/smpc (Last accessed July 2018).